Comparative studies of the diagnosis and treatment of cerebral cavernous malformations in adults: systematic review
- 31 January 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Acta Neurochirurgica
- Vol. 155 (4), 643-649
- https://doi.org/10.1007/s00701-013-1621-4
Abstract
Cerebral cavernous malformation (CCM) management decisions are usually made after CCM diagnosis is suspected or definitively diagnosed on axial imaging by indirectly comparing a surgeon’s estimate of operative morbidity and mortality against published estimates of CCM untreated clinical course. We used comprehensive electronic strategies to search OVID Medline and EMBASE for original studies published before 2011 of ≥20 adults with CCM that (a) evaluated diagnostic test accuracy, or (b) compared treatment with microsurgery or stereotactic radiosurgery against conservative management in a concurrent or historical control group and reported clinical outcome(s). We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group’s approach to identify level 1 or level 2 studies according to the Oxford Centre for Evidence-Based Medicine’s 2011 criteria. We found one eligible diagnostic test accuracy study of 72 patients with brain masses accompanied by vasogenic edema and substantial amounts of blood, which found that hyperintense perilesional signal on T1-weighted magnetic resonance imaging could differentiate CCM from other causes with excellent specificity (98 %) and reasonable sensitivity (62 %). We found five potentially eligible observational studies of adults with a CCM that had already bled, but none met level 2 criteria for a “dramatic” effect (the conventionally calculated probability of the two groups of observations coming from the same population should be less than 0.01 and a rate ratio greater than 10). We found 11 potentially eligible observational studies of adults with CCM and epilepsy, but nine studies did not demonstrate dramatic effects and the remaining two studies showed dramatic effects, but they were at high risk of bias. To address the absence of level 1 or 2 evidence to support CCM treatment decisions, there is a need for large studies of CCM treatment with a concurrent control group, ideally with randomized treatment allocation.Keywords
This publication has 44 references indexed in Scilit:
- Prospective hemorrhage risk of intracerebral cavernous malformationsNeurology, 2012
- Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort studyThe Lancet Neurology, 2012
- Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic reviewNeurosurgical Focus, 2010
- Hemorrhage From Cavernous Malformations of the BrainStroke, 2008
- Grading quality of evidence and strength of recommendationsBMJ, 2004
- Prospective, Population-Based Detection of Intracranial Vascular Malformations in AdultsStroke, 2003
- Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patientsNeurosurgical Review, 2002
- Glycoprotein IIb/IIIa blockade and thrombolytics: Early lessons from the SPEED and GUSTO IV trialsAmerican Heart Journal, 1999
- Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992Neurology, 1996
- Natural history of intracranial cavernous malformationsJournal of Neurosurgery, 1995